Lifetime Circulatory Support Must Not Be Restricted to Transplant Centers

Heart Failure Clinics

Volumn 3, Issue 3, 2007, Pages 369-375

  Westaby, Stephen ^a  

^a JOHN RADCLIFFE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ASSISTED CIRCULATION; BUDGET; CARDIOGENIC SHOCK; COMORBIDITY; HEALTH CARE; HEALTH CARE COST; HEART ASSIST DEVICE; HEART FAILURE; HEART LEFT VENTRICLE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART TRANSPLANTATION; HEMODIALYSIS; HUMAN; KIDNEY DISEASE; REVIEW; SURVIVAL;

HEART FAILURE, CONGESTIVE; HEART TRANSPLANTATION; HEART-ASSIST DEVICES; HUMANS; MONITORING, PHYSIOLOGIC; PROSTHESIS DESIGN; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIALS; SURVIVAL ANALYSIS; VENTRICULAR DYSFUNCTION, LEFT;

EID: 34548127071     PISSN: 15517136     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hfc.2007.05.008     Document Type: Review

References (19)

1. Stewart S. Financial aspects of heart failure programs of care. Eur J Heart Fail 7 (2005) 423-428
2. Redfield M.M. Heart failure-an epidemic of uncertain proportions. N Engl J Med 347 (2002) 1442-1444
3. Hunt S.A. Taking heart-cardiac transplantation, past, present and future. N Engl J Med 355 (2006) 231-235
4. Lee H., Mans B., Taub K., et al. Cost analysis of ongoing care of patients with end stage renal disease: the impact of dialysis modality and dialysis access. Am J Kidney Dis 40 (2002) 611-622
5. Navia J.L., McCarthy P.M., Hoercher K.J., et al. Do left ventricular assist device (LVAD) bridge to transplant outcomes predict the results of permanent LVAD implantation. Ann Thorac Surg 74 (2002) 2051-2063
6. Kayala A.V., Tector A.J., Crouch J.D., et al. Comparison of Novacor and HeartMate vented electric left ventricular assist devices in a single institution. J Heart Lung Transplant 11 (2005) 1973-1975
7. Pae W.E., Miller C.A., Mathews Y., et al. Ventricular assist devices for postcardiotomy cardiogenic shock. A combined registry experience. J Thorac Cardiovasc Surg 104 (1992) 541-553
8. Frazier O.H., Rose A.N., McCarthy P.M., et al. Improved mortality and rehabilitation of transplant candidates treated with a long-term implantable left ventricular assist device. Ann Surg 222 (1995) 327-328
9. Zhang J., and Narula J. Molecular biology of myocardial recovery. Surg Clin North Am 84 (2004) 223-242
10. Hetzer R., Muller J., Weng Y., et al. Cardiac recovery in dilated cardiomyopathy by unloading with a left ventricular assist device. Ann Thorac Surg 68 (1999) 742-749
11. Sharples L.D., Buxton M.J., and Caine N. Evaluation of the left ventricular assist device programme in the United Kingdom. J Heart Lung Transplant 25 Suppl 1 (2006) 80-81
12. Rose E.A., Gelijns A.C., Moskowitz A.J., et al., Randomised Evaulation of Mechnical Assistance for the Treatment of Congestive Heart Failure (REMATCH) Study Group. Long-term mechanical left ventricular assistance for end-stage heart failure. N Engl J Med 345 (2001) 1435-1443
13. The United States Renal Data System. 2004 annual data report. Available at: http://www.usrds.org/. Accessed June 15, 2007.
14. Woller K.C., and Drexler H. Clinical applications of stem cells for the heart. Circ Res 96 (2005) 151-163
15. Westaby S. Ventricular assist device as destination therapy. Surg Clin North Am 84 (2004) 91-123
16. Saito S., Nishinaka T., and Westaby S. Hemodynamics of chronic non-pulsatile flow: implications for development. Surg Clin North Am 84 (2004) 61-74
17. Westaby S., Jarvik R., Freeland A., et al. Post auricular percutaneous power delivery for permanent mechanical circulatory support. J Thorac Cardiovasc Surg 123 (2002) 977-983
18. Westaby S., Frazier O.H., and Banning A. Six years of continuous circulatory support. N Engl J Med 355 (2006) 325-327
19. Siegenthaler M., Frazier O.H., Westaby S., et al. Mechanical reliability of the Jarvik 2000 Heart. Ann Thorac Surg 81 (2006) 1752-1758